Advances in brain stimulation for depression

Anna Wani, Kenneth Trevino, Paige Marnell, Mustafa M. Husain

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BACKGROUND: Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the population. Although a range of antidepressant treatments have been developed, many patients are unable to obtain an adequate therapeutic response despite completing several antidepressant medication trials. As a result, neurostimulation treatment modalities have been developed as potential alternatives. This article provides an overview of advances in neurostimulation for treating depression. METHODS: We conducted a comprehensive review of the neurostimulation literature to identify recent findings involving the description and rationale, efficacy, and side effects of vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), and deep brain stimulation (DBS). RESULTS: VNS and TMS are the newest neurostimulation modalities that have been approved by the FDA for treating depression. VNS is approved for patients with treatment-resistant depression (TRD), while TMS has demonstrated efficacy only for milder forms of TRD. Despite demonstrated efficacy, further research is needed to address certain limitations and/or determine how best to utilize these forms of neurostimulation. Investigational forms of neurostimulation include MST and DBS. Although MST and DBS have demonstrated promise as a depression treatment, research is still being conducted to determine and/or enhance their antidepressant properties. CONCLUSIONS: Although electroconvulsive therapy remains the primary and most effective treatment option for patients with severe TRD, there have been considerable gains in the field of neurostimulation. Many of the neurostimulation techniques described in this review represent promising treatment alternatives for patients with TRD.

Original languageEnglish (US)
Pages (from-to)217-224
Number of pages8
JournalAnnals of Clinical Psychiatry
Volume25
Issue number3
StatePublished - Aug 2013

Fingerprint

Depression
Treatment-Resistant Depressive Disorder
Brain
Vagus Nerve Stimulation
Deep Brain Stimulation
Transcranial Magnetic Stimulation
Antidepressive Agents
Seizures
Therapeutics
Electroconvulsive Therapy
Major Depressive Disorder
Research
Psychiatry
Population

Keywords

  • Deep brain stimulation
  • Magnetic seizure therapy
  • Neurostimulation
  • Transcranial magnetic stimulation
  • Treatment-resistant depression
  • Vagus nerve stimulation

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Advances in brain stimulation for depression. / Wani, Anna; Trevino, Kenneth; Marnell, Paige; Husain, Mustafa M.

In: Annals of Clinical Psychiatry, Vol. 25, No. 3, 08.2013, p. 217-224.

Research output: Contribution to journalArticle

Wani, A, Trevino, K, Marnell, P & Husain, MM 2013, 'Advances in brain stimulation for depression', Annals of Clinical Psychiatry, vol. 25, no. 3, pp. 217-224.
Wani, Anna ; Trevino, Kenneth ; Marnell, Paige ; Husain, Mustafa M. / Advances in brain stimulation for depression. In: Annals of Clinical Psychiatry. 2013 ; Vol. 25, No. 3. pp. 217-224.
@article{dd72abbff27e455788d713b10d474601,
title = "Advances in brain stimulation for depression",
abstract = "BACKGROUND: Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the population. Although a range of antidepressant treatments have been developed, many patients are unable to obtain an adequate therapeutic response despite completing several antidepressant medication trials. As a result, neurostimulation treatment modalities have been developed as potential alternatives. This article provides an overview of advances in neurostimulation for treating depression. METHODS: We conducted a comprehensive review of the neurostimulation literature to identify recent findings involving the description and rationale, efficacy, and side effects of vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), and deep brain stimulation (DBS). RESULTS: VNS and TMS are the newest neurostimulation modalities that have been approved by the FDA for treating depression. VNS is approved for patients with treatment-resistant depression (TRD), while TMS has demonstrated efficacy only for milder forms of TRD. Despite demonstrated efficacy, further research is needed to address certain limitations and/or determine how best to utilize these forms of neurostimulation. Investigational forms of neurostimulation include MST and DBS. Although MST and DBS have demonstrated promise as a depression treatment, research is still being conducted to determine and/or enhance their antidepressant properties. CONCLUSIONS: Although electroconvulsive therapy remains the primary and most effective treatment option for patients with severe TRD, there have been considerable gains in the field of neurostimulation. Many of the neurostimulation techniques described in this review represent promising treatment alternatives for patients with TRD.",
keywords = "Deep brain stimulation, Magnetic seizure therapy, Neurostimulation, Transcranial magnetic stimulation, Treatment-resistant depression, Vagus nerve stimulation",
author = "Anna Wani and Kenneth Trevino and Paige Marnell and Husain, {Mustafa M.}",
year = "2013",
month = "8",
language = "English (US)",
volume = "25",
pages = "217--224",
journal = "Annals of Clinical Psychiatry",
issn = "1040-1237",
publisher = "Dowden Health Media,Inc",
number = "3",

}

TY - JOUR

T1 - Advances in brain stimulation for depression

AU - Wani, Anna

AU - Trevino, Kenneth

AU - Marnell, Paige

AU - Husain, Mustafa M.

PY - 2013/8

Y1 - 2013/8

N2 - BACKGROUND: Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the population. Although a range of antidepressant treatments have been developed, many patients are unable to obtain an adequate therapeutic response despite completing several antidepressant medication trials. As a result, neurostimulation treatment modalities have been developed as potential alternatives. This article provides an overview of advances in neurostimulation for treating depression. METHODS: We conducted a comprehensive review of the neurostimulation literature to identify recent findings involving the description and rationale, efficacy, and side effects of vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), and deep brain stimulation (DBS). RESULTS: VNS and TMS are the newest neurostimulation modalities that have been approved by the FDA for treating depression. VNS is approved for patients with treatment-resistant depression (TRD), while TMS has demonstrated efficacy only for milder forms of TRD. Despite demonstrated efficacy, further research is needed to address certain limitations and/or determine how best to utilize these forms of neurostimulation. Investigational forms of neurostimulation include MST and DBS. Although MST and DBS have demonstrated promise as a depression treatment, research is still being conducted to determine and/or enhance their antidepressant properties. CONCLUSIONS: Although electroconvulsive therapy remains the primary and most effective treatment option for patients with severe TRD, there have been considerable gains in the field of neurostimulation. Many of the neurostimulation techniques described in this review represent promising treatment alternatives for patients with TRD.

AB - BACKGROUND: Major depressive disorder is a common and debilitating psychiatric disorder that negatively impacts a large portion of the population. Although a range of antidepressant treatments have been developed, many patients are unable to obtain an adequate therapeutic response despite completing several antidepressant medication trials. As a result, neurostimulation treatment modalities have been developed as potential alternatives. This article provides an overview of advances in neurostimulation for treating depression. METHODS: We conducted a comprehensive review of the neurostimulation literature to identify recent findings involving the description and rationale, efficacy, and side effects of vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS), magnetic seizure therapy (MST), and deep brain stimulation (DBS). RESULTS: VNS and TMS are the newest neurostimulation modalities that have been approved by the FDA for treating depression. VNS is approved for patients with treatment-resistant depression (TRD), while TMS has demonstrated efficacy only for milder forms of TRD. Despite demonstrated efficacy, further research is needed to address certain limitations and/or determine how best to utilize these forms of neurostimulation. Investigational forms of neurostimulation include MST and DBS. Although MST and DBS have demonstrated promise as a depression treatment, research is still being conducted to determine and/or enhance their antidepressant properties. CONCLUSIONS: Although electroconvulsive therapy remains the primary and most effective treatment option for patients with severe TRD, there have been considerable gains in the field of neurostimulation. Many of the neurostimulation techniques described in this review represent promising treatment alternatives for patients with TRD.

KW - Deep brain stimulation

KW - Magnetic seizure therapy

KW - Neurostimulation

KW - Transcranial magnetic stimulation

KW - Treatment-resistant depression

KW - Vagus nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=84886899347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886899347&partnerID=8YFLogxK

M3 - Article

C2 - 23926577

AN - SCOPUS:84886899347

VL - 25

SP - 217

EP - 224

JO - Annals of Clinical Psychiatry

JF - Annals of Clinical Psychiatry

SN - 1040-1237

IS - 3

ER -